載入...
The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma
BACKGROUND: The primary goal of current chemotherapy in hepatoblastoma (HB) is reduction of tumour volume and vitality to enable complete surgical resection and reduce risk of recurrence or metastatic disease. Drug resistance remains a major challenge for HB treatment. In some malignancies inhibitio...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3176244/ https://ncbi.nlm.nih.gov/pubmed/21854558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-362 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|